Scientific Director
GlaxoSmithKline
Kunal Taskar, Ph.D., is currently working as a GSK Fellow at GlaxoSmithKline, U.K. in DMPK, IVIVT R&D
department. His current role is that of Scientific Director, Global PBPK Modelling Team Leader at GSK.
Kunal completed his doctorate more than a decade ago and postdoctoral research at Texas Tech
University Health Sciences department, USA, in Quentin Smith’s lab with research focused on
Neuropharmacokinetics and role of transporters in drug delivery across the blood-brain barrier (BBB).
Kunal’s experience and research focus include: PBPK modeling for PK and dose predictions, drug-drug
interaction predictions and mechanistic understanding of the clinically occurring drug–drug interactions;
transporter mediated drug delivery and intracellular drug concentrations, especially the role of uptake
and efflux transporters in drug pharmacokinetics-pharmacodynamics in disease and toxicology; novel
transporters and role in drug disposition and use of endogenous probes for drug mediated transporter
modulations, application of PBPK modeling in special populations including pediatrics, pregnancy and
organ impairment.
Kunal is a member of American Society of Clinical Pharmacology and Therapeutics (ASCPT), International
Society for the Study of Xenobiotics (ISSX) and the International Brain Barriers Society. Kunal is a
member of several IQ consortiums including MIDD Pilot Program WG, Transporters, Induction PBPK and
Pediatric PBPK. He received the 2014 AAPS Pharmaceutical Research Meritorious Manuscript Award for
a manuscript that was published in the same journal in 2012. He has been actively publishing in this field
and has been invited for several invited talks and workshops at international conferences
Disclosure information not submitted.
Friday, May 13, 2022
8:00 AM – 12:00 PM ET
.png)